Treatment of Anaphylaxis and Modifications During Covid-19
DOI:
https://doi.org/10.58931/cait.2021.1214Abstract
Anaphylaxis is defined as a serious allergic reaction that is rapid in onset and is potentially life-threatening. The lifetime prevalence of anaphylaxis is between 1.6 to 5.1% with the largest number of incident cases among children and adolescents. Most episodes of anaphylaxis are immunoglobulin- E (IgE) mediated with foods, medications and stinging insects being the most common triggers.6 While various definitions of anaphylaxis exist, 2,7–9 most rely on two body systems being affected, with some combination of cutaneous, respiratory, gastrointestinal and/or cardiac symptoms. Cutaneous symptoms are by far the most common, reported in over 80% of anaphylaxis, followed by respiratory then gastrointestinal involvement.
References
Golden DBK, Demain J, Freeman T, Graft D, Tankersley M, Tracy J, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017 Jan;118(1):28-54. doi:10.1016/j.anai.2016.10.031
Simons FER. Anaphylaxis. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81. doi:10.1016/j.jaci.2009.12.981
Sturm GJ, Kranzelbinder B, Schuster C, et al. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol. 2014 Jun;133(6):1635-43.e1. doi:10.1016/j.jaci.2013.10.046
Mauriello PM, Barde SH, Georgitis JW, Reisman RE. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol. 1984 Oct;74(4 Pt 1):494-8. doi:10.1016/0091-6749(84)90384-1
Golden DBK. Anaphylaxis to Insect Stings. Immunol Allergy Clin North Am. 2015 May;35(2):287-302. doi:10.1016/j.iac.2015.01.007
Oude Elberink JNG, van der Heide S, Guyatt GH, Dubois AEJ. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. JJ Allergy Clin Immunol. 2006 Sep;118(3):699-704. doi:10.1016/j.jaci.2006.03.049
Golden DBK, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of Allergy to Insect Stings in Children, with and without Venom Immunotherapy. N Engl J Med. 2004 Aug 12;351(7):668-74. doi:10.1056/NEJMoa022952
